Where does Spinogenix's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Spinogenix's 7 recorded funding rounds.

Premier Alternatives

Spinogenix

Los Angeles, CA · Founded 2016 · Privately Held (backing)

Operator of a biopharmaceutical company intended to restore the brain connections and functions lost in brain injury and neurodegenerative diseases. Spinogenix is based in Los Angeles, CA and was founded in 2016. It was valued at $335 million at its later-stage round in Mar 2026, the last priced event on record. It has raised $27.4 million across 7 recorded rounds; the latest was a $10.6 million early-stage round in Nov 2025.

PMV mark · valuation

$335.0M

Oct 2026

Priced at

its later-stage round

Mar 2026

Total raised

$27.4M

Last round

Early Stage VC

Nov 2025

Cap table — not yet on record

Spinogenix's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Spinogenix with a free account

·Watch Spinogenix: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Spinogenix

Where does Spinogenix's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Spinogenix's 7 recorded funding rounds.